Literature DB >> 10718653

High-performance liquid chromatographic assay for minocycline in human plasma and parotid saliva.

V Orti1, M Audran, P Gibert, G Bougard, F Bressolle.   

Abstract

A sensitive and specific high-performance liquid chromatographic (HPLC) method with UV detection was developed for the determination of minocycline in human plasma and parotid saliva samples. Samples were extracted using an Oasis HLB cartridge and were injected into a C8 Nucleosil column. The HPLC eluent contained acetonitrile-methanol-distilled water-0.1% trifluoroacetic acid (25:2:72.9:0.1, v/v). Demeclocycline was used as internal standard. The assay showed linearity in the tested range of 0.1-25 microg/ml. The limit of quantitation was 100 ng/ml. Recovery from plasma or parotid saliva averaged 95%. Precision expressed as %CV was in the range 0.2-17% (limit of quantitation). Accuracy ranged from 93 to 111%. In the two matrices studied at 20 and 4 degrees C, rapid degradation of the drug occurred. Frozen at -30 degrees C, this drug was stable for at least 2 months, the percent recovery averaged 90%. The method's ability to quantify minocycline with precision, accuracy and sensitivity makes it useful in pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718653     DOI: 10.1016/s0378-4347(99)00547-2

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  3 in total

1.  Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

Authors:  Susan C Fagan; Jennifer L Waller; Fenwick T Nichols; David J Edwards; L Creed Pettigrew; Wayne M Clark; Christiana E Hall; Jeffrey A Switzer; Adviye Ergul; David C Hess
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

2.  Metal ion-assisted self-assembly of complexes for controlled and sustained release of minocycline for biomedical applications.

Authors:  Zhiling Zhang; Zhicheng Wang; Jia Nong; Camilla A Nix; Hai-Feng Ji; Yinghui Zhong
Journal:  Biofabrication       Date:  2015-01-20       Impact factor: 9.954

3.  Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.

Authors:  Lin Xu; Susan C Fagan; Jennifer L Waller; David Edwards; Cesar V Borlongan; Jianqing Zheng; William D Hill; Giora Feuerstein; David C Hess
Journal:  BMC Neurol       Date:  2004-04-26       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.